Vanguard Fiduciary Trust
ICCC icon

Vanguard Fiduciary Trust’s ImmuCell ICCC Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Sell
37,766
-4,903
-11% -$43.3K ﹤0.01% 3361
2026
Q1 		$270K Buy
+42,669
New +$273K ﹤0.01% 3420

Other funds holding ICCC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust's ICCC Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its ImmuCell (ICCC) stake by 11% in Q2 2026, selling an estimated $43.3K and leaving 37,766 shares worth $380K. The position accounts for ﹤0.01% of the portfolio, ranked #3361.

Vanguard Fiduciary Trust first reported a position in ICCC in Q1 2026 and has held it in 2 quarters since. 30 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

  • Vanguard Fiduciary Trust held 37,766 shares of ImmuCell worth $380K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 4,903 ImmuCell shares in Q2 2026, an estimated $43.3K.
  • ImmuCell made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3361 holding.
  • Vanguard Fiduciary Trust first reported a position in ImmuCell in Q1 2026 and has held it in 2 quarters since.
  • 30 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.